Webcast CME

Basic and Clinical Immunology for the Busy Clinician Webcasts

Insights and Advances in Biologic Therapies of Immune Mediated Inflammatory Diseases, Vasculitis and Crystal Mediated Inflammatory Diseases, and Gout

Release date: April 19, 2024
Expiration date: April 18, 2026

Estimated Time of Completion: 2 hours and 45 minutes

Session Agenda

Unveiling Novel Pathways: Exploring Immune Dysregulation in Spondyloarthropathy
Philip J. Mease, MD, University of Washington School of Medicine

Guidelines Unveiled: Navigating Spondyloarthropathy Treatment Pathways – Eeny, Meeny, Miny, Moe?
M. Elaine Husni, MD, MPH, Cleveland Clinic

Beyond TNF Blockade: Breakthroughs in Rheumatoid Arthritis Pathogenesis
John R.P. Tessar, MD, FACR, Arizona Arthritis & Rheumatology Associates, P.C.

What’s New in Vasculitis
Adam Brown, MD, Cleveland Clinic

Crystal Clear: Critically Appraising the Role of Biologic Therapies in Crystal-Related Diseases
Brian Mandell, MD, PhD, Cleveland Clinic

Description

Watch Basic and Clinical Immunology for the Busy Clinician on-demand webcast series to receive instruction from leading experts in the field of immunology. The series begins with an overview of advances in immunology, and then leads into a review of hot topics in immunology. Education also focuses on the standard of care for SpA and PsA, along with new developments in treatments for SAPHO, SLE, and complement and vasculitis. The webcasts are also devoted to topics related to COVID-19 and rheumatologists/clinical immunologists, including vaccines, long COVID, and cytokine storm, wellness and treating the COVID-19 patient long-term.

 

Learning Objectives

  • Review the various treatment guidelines for axSpA and PsA.
  • Compare and contrast treatment guideline methodology.
  • Discuss treatment management strategies that may influence patient care.
  • Describe recent advances in the treatment of gout with biologic therapies and the role of complement in systemic vasculitis.

Target Audience

The online series is directed to rheumatologists; dermatologists; infectious disease clinicians; allergists; clinical immunologists; specialists in integrative medicine, preventive medicine, wellness, and primary care; nurses; physician assistants, and other health care professionals caring for patients with immunologic diseases.

Accreditation

In support of improving patient care, Cleveland Clinic Center for Continuing Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians / American Medical Association (AMA)
Cleveland Clinic Center for Continuing Education designates this internet enduring activity for a maximum of 2.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.

Nurses / American Nurses Credentialing Center (ANCC)
Cleveland Clinic Center for Continuing Education designates this internet enduring activity for a maximum of 2.75 ANCC contact hours.

Physician Assistants / American Academy of PAs (AAPA)
Cleveland Clinic Center for Continuing Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 2.75 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Certificate of Participation
A certificate of participation will be provided to other health care professionals for requesting credits in accordance with their professional boards and/or associations.

Activity Director and Faculty

Activity Director

Cassandra Calabrese, DO
Department of Rheumatic and Immunologic Diseases
Orthopaedic and Rheumatologic Institute
Cleveland Clinic
Cleveland, OH

Leonard H. Calabrese, DO
Professor of Medicine
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
R.J. Fasenmyer Chair of Clinical Immunology
Department of Rheumatic and Immunologic Diseases
Orthopaedic and Rheumatologic Institute
Cleveland Clinic
Cleveland, OH

M. Elaine Husni, MD, MPH
Director, Arthritis and Musculoskeletal Treatment Center
Vice Chair of Rheumatology
Department of Rheumatic and Immunologic Diseases
Orthopaedic and Rheumatologic Institute
Cleveland Clinic
Cleveland, OH

Additional Planners

Debra Kangisser, PA-C
Clinical Affairs, PA Services
Cleveland Clinic
Cleveland, OH

Cindy Willis, DNP
Cleveland Clinic
Cleveland, OH

Faculty

Adam Brown, MD
Department of Rheumatologic and Immunologic Disease
Cleveland Clinic
Cleveland, OH

Brian Mandell, MD, PhD
Department of Rheumatologic and Immunologic Disease
Cleveland Clinic
Cleveland, OH

Philip J. Mease, MD
Rheumatologist, Seattle Rheumatology Associates
Director of Rheumatology Research
Swedish Medical Center/Providence-St Joseph Health
Clinical Professor, University of Washington School of Medicine
Seattle, WA

John R.P. Tessar, MD, FACR
Arizona Arthritis & Rheumatology Associates, P.C.
Phoenix, AZ

CME Disclaimer

The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.

Disclosures

In accordance with the Standards for Integrity and Independence issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Center for Continuing Education mitigates all relevant conflicts of interest to ensure CE activities are free of commercial bias.

The following faculty have indicated that they may have a relationship, which in the context of their presentation(s), could be perceived as a potential conflict of interest:

Adam Brown, MD  

Amgen, Chemocentryx

Consulting
Teaching and Speaking

Cassandra Calabrese, DO  

Astra Zeneca, Lilly

Consulting

Sarofi-Regererun

Consulting
Teaching and Speaking

Leonard Calabrese, DO  

Astra Zeneca

Teaching and Speaking

Abbvie Pharmaceuticals, Sanofi Aventis, Novartis

Consulting

Genentech/Roche

Consulting
Advisor or review panel participant
Teaching and Speaking

Janssen, UCB

Consulting
Teaching and Speaking

M. Elaine Husni, MD  

Abbvie Pharmaceuticals, Amgen, Bristol-Myers Squibb Co., Janssen, Lilly, Regeneron

Consulting
Advisor or review panel participant

Novartis Pharmaceuticals

Consulting
Advisor or review panel participant
Teaching and Speaking

Pfizer, Inc.

Advisor or review panel participant

UCB, Inc.

Consulting

National Psoriasis Foundation

Other activities from which remuneration is received or expected: grant support to the project
Research: PI NPF grant: Mind Matters: A high touch, low cost approach to improving mental health outcomes in patients with Psoriatic Disease

Brian Mandell, MD  

Horizon Pharma

Consulting
Research: DSMB

Philip Mease, MD  

Abbvie Pharmaceuticals, Amgen, Bristol-Myers Squibb Co., Janssen, Lilly, Pfizer, UCB

Consulting
Teaching and Speaking

Boehringer Ingelheim, Corrona, LLC, Galapagos, Gilead Sciences, Inc., GlaxoSmithKline, Novartis, Sun Pharmaceutical Industries Ltd.

Consulting

John R. P. Tesser, MD  

Abbvie Pharmaceuticals, Astrazeneca Pharmaceuticals, Janssen

Consulting
Teaching and Speaking
Research: PI and co-PI

Alpine, Aqtual, Biogen Inc., Corevitas, IGM Biosciences

Research: co-PI

Eli Lilly

Consulting
Teaching and Speaking
Research: PI

Novartis, UCB

Consulting

Aurinia Pharmaceuticals

Teaching and Speaking
Research: PI

Pfizer, Sanofi

Consulting
Teaching and Speaking

Samumed, LLC, Setpoint Medical

Consulting
Research: PI

Bendcare, Horizon Therapeutics, Kolon TissueGene

Research: PI

GSK

Teaching and Speaking
Research: co-PI

Amgen

Teaching and Speaking

The following faculty have indicated they have no relationship which, in the context of their presentation(s), could be perceived as a potential conflict of interest:

Debra Kangisser, PA-C

Cindy Willis, DNP

Acknowledgment

The Cleveland Clinic Center for Continuing Education acknowledges educational grants for partial support of this activity from:

AbbVie, Inc.
AstraZeneca Pharmaceuticals
Bristol-Myers Squibb Company
Genentech, Inc.
Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC
Pfizer Inc.


This CME activity was produced by the Cleveland Clinic Center for Continuing Education, Cleveland Clinic’s R.J Fasenmyer Center for Clinical Immunology.